Curis
CRIS
#10201
Rank
NZ$30.21 M
Marketcap
NZ$2.34
Share price
0.00%
Change (1 day)
-65.20%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$3.4 Million

According to Curis's latest financial reports the company's total debt is NZ$3.4 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$5.23 M18.55%
2023-12-31NZ$4.41 M-28.82%
2022-12-31NZ$6.2 M-15.88%
2021-12-31NZ$7.37 M-30.51%
2020-12-31NZ$10.61 M4208.21%
2019-12-31NZ$0.24 M-99.53%
2018-12-31NZ$52.9 M-9.59%
2017-12-31NZ$58.51 M104.08%
2016-12-31NZ$28.67 M-18.8%
2015-12-31NZ$35.3 M-2.24%
2014-12-31NZ$36.11 M-2.86%
2013-12-31NZ$37.18 M2.51%
2012-12-31NZ$36.27 M
2008-12-31N/A-100%
2007-12-31NZ$0.52 M-81.24%
2006-12-31NZ$2.8 M-67.07%
2005-12-31NZ$8.53 M-11.13%
2004-12-31NZ$9.6 M10.34%
2003-12-31NZ$8.7 M-63.32%
2002-12-31NZ$23.72 M-6.79%
2001-12-31NZ$25.44 M84.07%
2000-12-31NZ$13.82 M432.55%
1999-12-31NZ$2.59 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Exelixis
EXEL
NZ$0.30 B 8,866.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.14 B 33,594.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$49.92 M 1,365.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$4.53 M 33.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.32 B 3,091,769.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.35 B 2,593,446.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$17.24 M 406.30%๐Ÿ‡บ๐Ÿ‡ธ USA